116 related articles for article (PubMed ID: 10423250)
1. Receptor activation by human C5a des Arg74 but not intact C5a is dependent on an interaction between Glu199 of the receptor and Lys68 of the ligand.
Crass T; Bautsch W; Cain SA; Pease JE; Monk PN
Biochemistry; 1999 Jul; 38(30):9712-7. PubMed ID: 10423250
[TBL] [Abstract][Full Text] [Related]
2. Mutation of glutamate 199 of the human C5a receptor defines a binding site for ligand distinct from the receptor N terminus.
Monk PN; Barker MD; Partridge LJ; Pease JE
J Biol Chem; 1995 Jul; 270(28):16625-9. PubMed ID: 7622471
[TBL] [Abstract][Full Text] [Related]
3. The C terminus of the human C5a receptor (CD88) is required for normal ligand-dependent receptor internalization.
Bock D; Martin U; Gärtner S; Rheinheimer C; Raffetseder U; Arseniev L; Barker MD; Monk PN; Bautsch W; Köhl J; Klos A
Eur J Immunol; 1997 Jun; 27(6):1522-9. PubMed ID: 9209506
[TBL] [Abstract][Full Text] [Related]
4. Mapping the ligand-binding site on the C5a receptor: arginine74 of C5a contacts aspartate282 of the C5a receptor.
Cain SA; Coughlan T; Monk PN
Biochemistry; 2001 Nov; 40(46):14047-52. PubMed ID: 11705397
[TBL] [Abstract][Full Text] [Related]
5. Direct binding of a fragment of the Wiskott-Aldrich syndrome protein to the C-terminal end of the anaphylatoxin C5a receptor.
Tardif M; Brouchon L; Rabiet MJ; Boulay F
Biochem J; 2003 Jun; 372(Pt 2):453-63. PubMed ID: 12600272
[TBL] [Abstract][Full Text] [Related]
6. The influence of Lys68 in decepeptide agonists of C5a on C5a receptor binding, activation and selectivity.
Vogen SM; Finch AM; Wadi SK; Thatcher J; Monk PN; Taylor SM; Sanderson SD
J Pept Res; 1999 Jan; 53(1):8-17. PubMed ID: 10195437
[TBL] [Abstract][Full Text] [Related]
7. Mutation of aspartate 82 of the human C5a receptor abolishes the secretory response to human C5a in transfected rat basophilic leukemia cells.
Monk PN; Pease JE; Marland G; Barker MD
Eur J Immunol; 1994 Nov; 24(11):2922-5. PubMed ID: 7957584
[TBL] [Abstract][Full Text] [Related]
8. Selection of a C5a receptor antagonist from phage libraries attenuating the inflammatory response in immune complex disease and ischemia/reperfusion injury.
Heller T; Hennecke M; Baumann U; Gessner JE; zu Vilsendorf AM; Baensch M; Boulay F; Kola A; Klos A; Bautsch W; Köhl J
J Immunol; 1999 Jul; 163(2):985-94. PubMed ID: 10395696
[TBL] [Abstract][Full Text] [Related]
9. Plasma clearance of the human C5a anaphylatoxin by binding to leucocyte C5a receptors.
Oppermann M; Götze O
Immunology; 1994 Aug; 82(4):516-21. PubMed ID: 7835913
[TBL] [Abstract][Full Text] [Related]
10. The chemoattractant des-Arg74-C5a regulates the expression of its own receptor on a monocyte-like cell line.
Barker MD; Jose PJ; Williams TJ; Burton DR
Biochem J; 1986 Jun; 236(2):621-4. PubMed ID: 3019322
[TBL] [Abstract][Full Text] [Related]
11. Site-specific mutagenesis of residues in the human C5a anaphylatoxin which are involved in possible interaction with the C5a receptor.
Bubeck P; Grötzinger J; Winkler M; Köhl J; Wollmer A; Klos A; Bautsch W
Eur J Biochem; 1994 Feb; 219(3):897-904. PubMed ID: 8112341
[TBL] [Abstract][Full Text] [Related]
12. Analysis of the C5a anaphylatoxin core domain using a C5a phage library selected on differentiated U937 cells.
Kola A; Baensch M; Bautsch W; Klos A; Köhl J
Mol Immunol; 1999 Feb; 36(2):145-52. PubMed ID: 10378686
[TBL] [Abstract][Full Text] [Related]
13. The role of the N-terminal domain of the complement fragment receptor C5L2 in ligand binding.
Scola AM; Higginbottom A; Partridge LJ; Reid RC; Woodruff T; Taylor SM; Fairlie DP; Monk PN
J Biol Chem; 2007 Feb; 282(6):3664-71. PubMed ID: 17158873
[TBL] [Abstract][Full Text] [Related]
14. Solution structure of a unique C5a semi-synthetic antagonist: implications in receptor binding.
Zhang X; Boyar W; Galakatos N; Gonnella NC
Protein Sci; 1997 Jan; 6(1):65-72. PubMed ID: 9007977
[TBL] [Abstract][Full Text] [Related]
15. Small molecular probes for G-protein-coupled C5a receptors: conformationally constrained antagonists derived from the C terminus of the human plasma protein C5a.
Wong AK; Finch AM; Pierens GK; Craik DJ; Taylor SM; Fairlie DP
J Med Chem; 1998 Aug; 41(18):3417-25. PubMed ID: 9719594
[TBL] [Abstract][Full Text] [Related]
16. Characterisation of C5a receptor agonists from phage display libraries.
Cain SA; Higginbottom A; Monk PN
Biochem Pharmacol; 2003 Nov; 66(9):1833-40. PubMed ID: 14563493
[TBL] [Abstract][Full Text] [Related]
17. Differential expression of the C5a receptor on the main cell types of rat liver as demonstrated with a novel monoclonal antibody and by C5a anaphylatoxin-induced Ca2+ release.
Schlaf G; Schieferdecker HL; Rothermel E; Jungermann K; Götze O
Lab Invest; 1999 Oct; 79(10):1287-97. PubMed ID: 10532591
[TBL] [Abstract][Full Text] [Related]
18. Modulation of ligand selectivity by mutation of the first extracellular loop of the human C5a receptor.
Cain SA; Woodruff TM; Taylor SM; Fairlie DP; Sanderson SD; Monk PN
Biochem Pharmacol; 2001 Jun; 61(12):1571-9. PubMed ID: 11377387
[TBL] [Abstract][Full Text] [Related]
19. Differential regulation of the C3a and C5a receptors (CD88) by IFN-gamma and PMA in U937 cells and related myeloblastic cell lines.
Burg M; Martin U; Bock D; Rheinheimer C; Köhl J; Bautsch W; Klos A
J Immunol; 1996 Dec; 157(12):5574-81. PubMed ID: 8955209
[TBL] [Abstract][Full Text] [Related]
20. C5L2, a nonsignaling C5A binding protein.
Okinaga S; Slattery D; Humbles A; Zsengeller Z; Morteau O; Kinrade MB; Brodbeck RM; Krause JE; Choe HR; Gerard NP; Gerard C
Biochemistry; 2003 Aug; 42(31):9406-15. PubMed ID: 12899627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
